Business Context and Reporting Period
This Form 8-K was filed by Neuralstem, Inc. on May 8, 2015. The report announces the financial results for the three months ended March 31, 2015, along with an update on business and clinical programs. The detailed results are contained in a press release attached as Exhibit 99.01.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.01) but are not present in the body of this 8-K document.
Material Changes
The filing does not provide specific data to compare against the prior comparable period. It only notes that the Company issued a press release announcing results and program updates for the quarter ended March 31, 2015.
Guidance, Outlook, and Risks
The Company provided a business and clinical programs update in the referenced press release. The filing explicitly states that the information furnished under Item 2.02 and Exhibit 99.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of such section, nor is it incorporated by reference in subsequent filings except as specifically stated.
Investor Verification Checklist
- Review Exhibit 99.01 (Press Release dated May 8, 2015) for specific financial figures, as they are not listed in the 8-K text.
- Verify the details of the clinical programs update mentioned in the press release.
- Note the legal disclaimer regarding the non-filing status of the press release content under Section 18 of the Exchange Act.
- Confirm the reporting period is the three months ended March 31, 2015.